nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Skin striae—Bleomycin—melanoma	0.0596	0.079	CcSEcCtD
Desonide—Folliculitis—Vemurafenib—melanoma	0.0498	0.0659	CcSEcCtD
Desonide—Induration—Bleomycin—melanoma	0.0424	0.0561	CcSEcCtD
Desonide—Folliculitis—Dactinomycin—melanoma	0.0281	0.0373	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1C—melanoma	0.02	0.0919	CbGpPWpGaD
Desonide—Skin exfoliation—Bleomycin—melanoma	0.0181	0.024	CcSEcCtD
Desonide—Viral infection—Temozolomide—melanoma	0.0177	0.0234	CcSEcCtD
Desonide—Infestation NOS—Vemurafenib—melanoma	0.0175	0.0232	CcSEcCtD
Desonide—Infestation—Vemurafenib—melanoma	0.0175	0.0232	CcSEcCtD
Desonide—Skin exfoliation—Carmustine—melanoma	0.0158	0.0209	CcSEcCtD
Desonide—Oedema peripheral—Vemurafenib—melanoma	0.0155	0.0205	CcSEcCtD
Desonide—Skin exfoliation—Temozolomide—melanoma	0.0153	0.0202	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—HOXB13—melanoma	0.0147	0.0673	CbGpPWpGaD
Desonide—Mediastinal disorder—Vemurafenib—melanoma	0.0142	0.0188	CcSEcCtD
Desonide—Erythema—Vemurafenib—melanoma	0.0137	0.0181	CcSEcCtD
Desonide—Cough—Vemurafenib—melanoma	0.0119	0.0158	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.0116	0.0153	CcSEcCtD
Desonide—Infection—Vemurafenib—melanoma	0.0111	0.0147	CcSEcCtD
Desonide—Nervous system disorder—Vemurafenib—melanoma	0.0109	0.0145	CcSEcCtD
Desonide—Skin disorder—Vemurafenib—melanoma	0.0108	0.0144	CcSEcCtD
Desonide—Blood pressure increased—Docetaxel—melanoma	0.0106	0.0141	CcSEcCtD
Desonide—Skin exfoliation—Docetaxel—melanoma	0.0102	0.0134	CcSEcCtD
Desonide—Hyperglycaemia—Carmustine—melanoma	0.00936	0.0124	CcSEcCtD
Desonide—Upper respiratory tract infection—Temozolomide—melanoma	0.00932	0.0123	CcSEcCtD
Desonide—Hyperglycaemia—Temozolomide—melanoma	0.00905	0.012	CcSEcCtD
Desonide—Infestation NOS—Temozolomide—melanoma	0.00894	0.0118	CcSEcCtD
Desonide—Infestation—Temozolomide—melanoma	0.00894	0.0118	CcSEcCtD
Desonide—Pharyngitis—Dactinomycin—melanoma	0.00881	0.0117	CcSEcCtD
Desonide—Erythema—Bleomycin—melanoma	0.00829	0.011	CcSEcCtD
Desonide—Oedema peripheral—Carmustine—melanoma	0.00819	0.0108	CcSEcCtD
Desonide—Pharyngitis—Temozolomide—melanoma	0.00797	0.0106	CcSEcCtD
Desonide—Oedema peripheral—Temozolomide—melanoma	0.00791	0.0105	CcSEcCtD
Desonide—Pruritus—Vemurafenib—melanoma	0.0079	0.0105	CcSEcCtD
Desonide—Erythema—Dactinomycin—melanoma	0.00773	0.0102	CcSEcCtD
Desonide—Mental disorder—Carmustine—melanoma	0.00728	0.00964	CcSEcCtD
Desonide—Mediastinal disorder—Temozolomide—melanoma	0.00724	0.00958	CcSEcCtD
Desonide—Erythema—Carmustine—melanoma	0.00723	0.00958	CcSEcCtD
Desonide—Cough—Bleomycin—melanoma	0.00723	0.00958	CcSEcCtD
Desonide—Rash—Vemurafenib—melanoma	0.00704	0.00932	CcSEcCtD
Desonide—Mental disorder—Temozolomide—melanoma	0.00703	0.00932	CcSEcCtD
Desonide—Dermatitis—Vemurafenib—melanoma	0.00703	0.00931	CcSEcCtD
Desonide—Headache—Vemurafenib—melanoma	0.00699	0.00926	CcSEcCtD
Desonide—Erythema—Temozolomide—melanoma	0.00699	0.00926	CcSEcCtD
Desonide—Infection—Bleomycin—melanoma	0.00672	0.0089	CcSEcCtD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—melanoma	0.00667	0.0306	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—ASIP—melanoma	0.00638	0.0293	CbGpPWpGaD
Desonide—Infection—Dactinomycin—melanoma	0.00627	0.0083	CcSEcCtD
Desonide—Cough—Temozolomide—melanoma	0.0061	0.00808	CcSEcCtD
Desonide—Infestation—Docetaxel—melanoma	0.00595	0.00788	CcSEcCtD
Desonide—Infestation NOS—Docetaxel—melanoma	0.00595	0.00788	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00591	0.00783	CcSEcCtD
Desonide—Infection—Carmustine—melanoma	0.00586	0.00777	CcSEcCtD
Desonide—Pain—Bleomycin—melanoma	0.00578	0.00766	CcSEcCtD
Desonide—Infection—Temozolomide—melanoma	0.00567	0.00751	CcSEcCtD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K2—melanoma	0.00565	0.0259	CbGpPWpGaD
Desonide—Nervous system disorder—Temozolomide—melanoma	0.00559	0.00741	CcSEcCtD
Desonide—Skin disorder—Temozolomide—melanoma	0.00554	0.00734	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00552	0.0253	CbGpPWpGaD
Desonide—Hyperhidrosis—Temozolomide—melanoma	0.00552	0.0073	CcSEcCtD
Desonide—Pain—Dactinomycin—melanoma	0.00539	0.00714	CcSEcCtD
Desonide—Pharyngitis—Docetaxel—melanoma	0.0053	0.00702	CcSEcCtD
Desonide—Oedema peripheral—Docetaxel—melanoma	0.00526	0.00697	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—NODAL—melanoma	0.00523	0.024	CbGpPWpGaD
Desonide—Pain—Carmustine—melanoma	0.00505	0.00669	CcSEcCtD
Desonide—Pain—Temozolomide—melanoma	0.00488	0.00646	CcSEcCtD
Desonide—Mediastinal disorder—Docetaxel—melanoma	0.00481	0.00637	CcSEcCtD
Desonide—Pruritus—Bleomycin—melanoma	0.00478	0.00634	CcSEcCtD
Desonide—Mental disorder—Docetaxel—melanoma	0.00468	0.0062	CcSEcCtD
Desonide—Erythema—Docetaxel—melanoma	0.00465	0.00616	CcSEcCtD
Desonide—Dexamethasone—CYP17A1—melanoma	0.00443	0.165	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—melanoma	0.00441	0.0202	CbGpPWpGaD
Desonide—Rash—Bleomycin—melanoma	0.00426	0.00565	CcSEcCtD
Desonide—Dermatitis—Bleomycin—melanoma	0.00426	0.00564	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—BCL2L11—melanoma	0.00426	0.0195	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—melanoma	0.00426	0.0195	CbGpPWpGaD
Desonide—Cough—Docetaxel—melanoma	0.00406	0.00537	CcSEcCtD
Desonide—Pruritus—Temozolomide—melanoma	0.00404	0.00535	CcSEcCtD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—melanoma	0.00401	0.0184	CbGpPWpGaD
Desonide—Rash—Dactinomycin—melanoma	0.00398	0.00527	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00393	0.00521	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—melanoma	0.00389	0.0178	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—NPPA—melanoma	0.00388	0.0178	CbGpPWpGaD
Desonide—Infection—Docetaxel—melanoma	0.00377	0.00499	CcSEcCtD
Desonide—Rash—Carmustine—melanoma	0.00372	0.00493	CcSEcCtD
Desonide—Nervous system disorder—Docetaxel—melanoma	0.00372	0.00493	CcSEcCtD
Desonide—Dermatitis—Carmustine—melanoma	0.00372	0.00493	CcSEcCtD
Desonide—Headache—Carmustine—melanoma	0.0037	0.0049	CcSEcCtD
Desonide—Skin disorder—Docetaxel—melanoma	0.00369	0.00488	CcSEcCtD
Desonide—Dexamethasone—NOS2—melanoma	0.00361	0.134	CrCbGaD
Desonide—NR3C1—Nuclear Receptors—VDR—melanoma	0.0036	0.0165	CbGpPWpGaD
Desonide—Rash—Temozolomide—melanoma	0.0036	0.00476	CcSEcCtD
Desonide—Dermatitis—Temozolomide—melanoma	0.00359	0.00476	CcSEcCtD
Desonide—Headache—Temozolomide—melanoma	0.00357	0.00473	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—ETS1—melanoma	0.00345	0.0158	CbGpPWpGaD
Desonide—Pain—Docetaxel—melanoma	0.00324	0.0043	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—MAP2—melanoma	0.00317	0.0145	CbGpPWpGaD
Desonide—Dexamethasone—CYP1B1—melanoma	0.00307	0.114	CrCbGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—VDR—melanoma	0.00284	0.013	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TP73—melanoma	0.00269	0.0124	CbGpPWpGaD
Desonide—Pruritus—Docetaxel—melanoma	0.00268	0.00355	CcSEcCtD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—melanoma	0.00256	0.0117	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—melanoma	0.00252	0.0116	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—melanoma	0.00252	0.0116	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—PPARG—melanoma	0.00251	0.0115	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—melanoma	0.0025	0.0114	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.00248	0.0113	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—melanoma	0.00244	0.0112	CbGpPWpGaD
Desonide—Rash—Docetaxel—melanoma	0.00239	0.00317	CcSEcCtD
Desonide—Dermatitis—Docetaxel—melanoma	0.00239	0.00317	CcSEcCtD
Desonide—Headache—Docetaxel—melanoma	0.00238	0.00315	CcSEcCtD
Desonide—NR3C1—Circadian Clock—HIF1A—melanoma	0.0022	0.0101	CbGpPWpGaD
Desonide—Methylprednisolone—ABCB1—melanoma	0.00219	0.0817	CrCbGaD
Desonide—Triamcinolone—PTGS2—melanoma	0.00217	0.081	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—EDN1—melanoma	0.00217	0.00996	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL10—melanoma	0.00215	0.00985	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CSF2—melanoma	0.00212	0.00974	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL4—melanoma	0.00209	0.00958	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—melanoma	0.00206	0.00946	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.00201	0.00924	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.00201	0.0092	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—melanoma	0.00198	0.00909	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.00196	0.00901	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.00191	0.00876	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—HLA-A—melanoma	0.00189	0.00868	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—melanoma	0.00187	0.00858	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—melanoma	0.00184	0.00844	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP1—melanoma	0.00183	0.00837	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—HIF1A—melanoma	0.00181	0.0083	CbGpPWpGaD
Desonide—Betamethasone—PTGS2—melanoma	0.00178	0.0663	CrCbGaD
Desonide—Prednisone—ALB—melanoma	0.00176	0.0655	CrCbGaD
Desonide—Prednisone—ABCB1—melanoma	0.00168	0.0625	CrCbGaD
Desonide—NR3C1—Endoderm Differentiation—NOTCH1—melanoma	0.00167	0.00765	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.00167	0.00763	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—APC—melanoma	0.00163	0.00748	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.00161	0.00738	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.0016	0.00731	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.00157	0.00719	CbGpPWpGaD
Desonide—Prednisolone—ABCB1—melanoma	0.00154	0.0576	CrCbGaD
Desonide—Betamethasone—ABCB1—melanoma	0.00151	0.0564	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.00151	0.00691	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.00146	0.00671	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—SOCS1—melanoma	0.00146	0.00669	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	0.0013	0.00594	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—E2F1—melanoma	0.00127	0.00581	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IFNG—melanoma	0.00126	0.00579	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—CLNS1A—melanoma	0.00126	0.00577	CbGpPWpGaD
Desonide—Hydrocortisone—ABCB1—melanoma	0.00118	0.044	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	0.00117	0.00538	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—FAS—melanoma	0.00117	0.00538	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	0.00115	0.00526	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	0.00113	0.00519	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL2—melanoma	0.00112	0.00515	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	0.00111	0.0051	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	0.00111	0.00508	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	0.00111	0.00507	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—HIF1A—melanoma	0.0011	0.00506	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—SKI—melanoma	0.0011	0.00505	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CCND1—melanoma	0.00109	0.00502	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	0.00108	0.00497	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP9—melanoma	0.00106	0.00487	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—PTEN—melanoma	0.00106	0.00484	CbGpPWpGaD
Desonide—Dexamethasone—PTGS2—melanoma	0.00104	0.0386	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	0.00103	0.00474	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	0.000989	0.00453	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000954	0.00437	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000942	0.00432	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PPARG—melanoma	0.000938	0.0043	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	0.000933	0.00428	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	0.000926	0.00425	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—RB1—melanoma	0.000898	0.00412	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IGF1—melanoma	0.00089	0.00408	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.000882	0.00405	CbGpPWpGaD
Desonide—Dexamethasone—ABCB1—melanoma	0.00088	0.0328	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—MYC—melanoma	0.000878	0.00402	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NPPA—melanoma	0.000863	0.00395	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	0.000795	0.00364	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000781	0.00358	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	0.000756	0.00347	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000721	0.0033	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—CTNNB1—melanoma	0.00066	0.00303	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL6—melanoma	0.00066	0.00302	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—CDKN1A—melanoma	0.000645	0.00296	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	0.000635	0.00291	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000619	0.00284	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000592	0.00271	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	0.000581	0.00266	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—STAT3—melanoma	0.000576	0.00264	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000571	0.00262	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000554	0.00254	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000542	0.00248	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPS3—melanoma	0.000539	0.00247	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000536	0.00246	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SKI—melanoma	0.000531	0.00243	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SNRPE—melanoma	0.000531	0.00243	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	0.000504	0.00231	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000502	0.0023	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TNF—melanoma	0.000498	0.00228	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—VDR—melanoma	0.000491	0.00225	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	0.000431	0.00197	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NPPA—melanoma	0.000415	0.0019	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6—melanoma	0.000402	0.00184	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	0.000363	0.00166	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	0.000347	0.00159	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PPARG—melanoma	0.000343	0.00157	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HDAC2—melanoma	0.000304	0.00139	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—CDKN2B—melanoma	0.000243	0.00111	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—VDR—melanoma	0.000237	0.00108	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PRKCA—melanoma	0.000218	0.001	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ERCC2—melanoma	0.000216	0.000992	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MYC—melanoma	0.000195	0.000895	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH1—melanoma	0.000175	0.000801	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PPARG—melanoma	0.000165	0.000756	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MAPK3—melanoma	9.67e-05	0.000443	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MYC—melanoma	9.4e-05	0.000431	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—melanoma	6.52e-05	0.000299	CbGpPWpGaD
